Empagliflozin
Back to search| Scientific Name: | Empagliflozin |
| Brand Name: | Glyxambi, Jardiance, Synjardy, Trijardy |
| Company Owner: | Not Available |
| Mechanism Of Action | The vast majority of glucose filtered through the glomerulus is reabsorbed within the proximal tubule, primarily via SGLT2 (sodium-glucose linked co-transporter-2) which is responsible for ~90% of the total glucose reabsorption within the kidneys. Na |
| Description of the Drug: | Empagliflozin is an SGLT2 inhibitor used to manage type 2 diabetes mellitus. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB09038
